Cytek Biosciences, Inc. (CTKB): Cost of Revenue
$97.03M
Year ended 2025-12-31
$96.68M
Trailing 12 months to 2026-06-30
+15.4%
3-year compound annual growth
+18.7%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $97.03M | +8.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $89.35M | +6.9% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $83.59M | +32.6% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $63.06M | +29.2% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $48.81M | +18.7% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $41.13M | n/a | 2023-03-01, From 2020-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $97.03M | +8.6% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $114.22M | -2.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $73.94M | +36.1% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $36.64M | -6.9% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $198.94M | +1.3% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $27.77M | +19.5% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $15.32M | -49.6% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $13.34M | +21.6% |
| Seer, Inc. (SEER) | 2025-12-31 | $8.11M | +14.0% |
Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗